941-926-6413

Board of Directors


Officers

  • Ron Beck, Board Chairman

    Senior VP, Manatee Area Executive Gulfside Bank
  • Brad Bryan, Vice Chairman

    Brad!Bryan Multimedia, Inc.
  • Patricia Entsminger, Treasurer

    Kerkering, Barberio & Co.
  • Gana Gilkey, Secretary

    Financial Manager, Michael A. Gilkey, Inc.

Board Member Emeritus

  • Judith Bell

    Retired, Non-profit Executive & Consultant

Ex-Officio

  • Robyn Faucy-Washington

    Chief Executive Officer, Neuro Challenge Foundation
    Office: 941-926-6413
    Cell: 941-320-9348
    This email address is being protected from spambots. You need JavaScript enabled to view it.

Board at Large

  • Kimberly Early, Director

    Sabal Trust Company
  • Salvatore Fontana, Director

    Retired from ExxonMobil
  • Steven Oppen, Director

    Retired Finance/ HR Executive
  • Cynthia Miller, Director

    VP, 1st Source Bank
  • Scott Payne, Director

    ICare Labs
  • Charles Slater, Director

    Retired
  • Emily Walsh, Director

    Publisher, Observer Media Group

Advisory Directors

  • Babette Bach, Esq.

    Retired Elder Law Attorney
  • Kelley Lavin

    Exec. VP, Group Publisher
  • Gale Rydel

    RN, Cigna

*as of March 2020*

Administrative Office and Mailing Address: 722 Apex Rd. Suite A, Sarasota, FL 34240

NEURO CHALLENGE FOUNDATION FOR PARKINSON'S IS A 501(C)(3) CHARITABLE ORGANIZATION. A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE (800-435-7352) WITHIN THE STATE OF FLORIDA. REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE. CH26789.
Copyright © 2020 NeuroChallenge Foundation. All Rights Reserved.
NOTION Design Group

COVID-19 Update:

The health and safety of our Parkinson’s community is our number one priority. Until further notice, Neuro Challenge's programs and services are being offered virtually.

Neuro Challenge's goal is to educate, engage and empower the Parkinson’s community. During these uncertain times we find it most important to provide information and resources that address COVID-19 and Parkinson’s Disease. Please visit our Covid-19 and PD page for more information. 

Covid-19 and PD